4888 Stock Overview
Stella Pharma Corporation engages in the research, development, manufacturing, and distribution of pharmaceuticals.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Stella Pharma Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥299.00 |
| 52 Week High | JP¥363.00 |
| 52 Week Low | JP¥229.00 |
| Beta | 1.06 |
| 1 Month Change | 2.75% |
| 3 Month Change | 13.26% |
| 1 Year Change | -16.25% |
| 3 Year Change | -46.13% |
| 5 Year Change | n/a |
| Change since IPO | -65.31% |
Recent News & Updates
Recent updates
Shareholder Returns
| 4888 | JP Pharmaceuticals | JP Market | |
|---|---|---|---|
| 7D | 6.8% | 0.8% | 0.8% |
| 1Y | -16.2% | 3.6% | 26.5% |
Return vs Industry: 4888 underperformed the JP Pharmaceuticals industry which returned 3.6% over the past year.
Return vs Market: 4888 underperformed the JP Market which returned 26.5% over the past year.
Price Volatility
| 4888 volatility | |
|---|---|
| 4888 Average Weekly Movement | 7.0% |
| Pharmaceuticals Industry Average Movement | 3.8% |
| Market Average Movement | 4.1% |
| 10% most volatile stocks in JP Market | 8.2% |
| 10% least volatile stocks in JP Market | 2.3% |
Stable Share Price: 4888 has not had significant price volatility in the past 3 months.
Volatility Over Time: 4888's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of JP stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 46 | n/a | www.stella-pharma.co.jp |
Stella Pharma Corporation engages in the research, development, manufacturing, and distribution of pharmaceuticals. The company develops drugs for boron neutron capture therapy (BNCT). Its product includes SPM-011, a boron-containing drug for BNCT used for treating head and neck cancer, recurrent malignant glioma and meningioma, and malignant melanoma and angiosarcoma.
Stella Pharma Corporation Fundamentals Summary
| 4888 fundamental statistics | |
|---|---|
| Market cap | JP¥9.12b |
| Earnings (TTM) | -JP¥764.00m |
| Revenue (TTM) | JP¥254.00m |
36.8x
P/S Ratio-12.2x
P/E RatioIs 4888 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4888 income statement (TTM) | |
|---|---|
| Revenue | JP¥254.00m |
| Cost of Revenue | JP¥44.00m |
| Gross Profit | JP¥210.00m |
| Other Expenses | JP¥974.00m |
| Earnings | -JP¥764.00m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 10, 2024
| Earnings per share (EPS) | -24.47 |
| Gross Margin | 82.68% |
| Net Profit Margin | -300.79% |
| Debt/Equity Ratio | 36.4% |
How did 4888 perform over the long term?
See historical performance and comparison